Differential Diagnosis for Urticarial Rash Post-Influenza Vaccination

Primary Differential Considerations

The Centers for Disease Control and Prevention notes that delayed allergic reactions to influenza vaccine can occur, despite the 29-day interval, as immediate reactions can occur after influenza vaccination, though typically within hours to days 1, 2
The Advisory Committee on Immunization Practices notes that persons with urticaria after influenza vaccination can receive future vaccines, but this patient's presentation with systemic symptoms suggests a more significant reaction 1
Hypersensitivity reactions to vaccine components beyond egg protein can manifest as delayed-type reactions 2
The American Academy of Allergy, Asthma, and Immunology suggests that drug eruptions typically occur within 2-3 weeks of medication initiation, and any medication taken within the past 2-3 weeks must be queried 3
Enteroviral infections cause macular rash with trunk and extremity distribution, though typically spare palms and soles, according to the Infectious Diseases Society of America 3
Human herpesvirus 6 can present with macular rash following high fever, though more common in children, it can reactivate in adults, as noted by the American Academy of Pediatrics 3

A complete blood count with differential should be performed to assess for eosinophilia, thrombocytopenia, or leukocytosis, as recommended by the American College of Physicians 3
A comprehensive metabolic panel should be performed to evaluate renal function and electrolytes, according to the National Kidney Foundation 3
If fever, rash, and thrombocytopenia/hyponatremia are present, doxycycline should be initiated immediately, without waiting for confirmatory testing, as recommended by the Centers for Disease Control and Prevention 3, 4

If urticarial vasculitis is suspected, skin biopsy should be performed immediately, and high-dose corticosteroids should be initiated if biopsy confirms vasculitis, as recommended by the American College of Rheumatology 2
If simple allergic urticaria is suspected, second-generation H1 antihistamines should be used at standard doses initially, and titrated to up to 4 times standard dose if inadequate response, as recommended by the American Academy of Allergy, Asthma, and Immunology 3
If vaccine hypersensitivity is suspected, the same influenza vaccine formulation should not be rechallenged, as recommended by the Advisory Committee on Immunization Practices 1, 5